Cargando…

E3-ubiquitin ligases and recent progress in osteoimmunology

Ubiquitin-mediated proteasomal degradation is a post-transcriptional protein modification that is comprised of various components including the 76-amino acid protein ubiquitin (Ub), Ub-activating enzyme (E1), Ub-conjugating enzyme (E2), ubiquitin ligase (E3), deubiquitinating enzyme (DUB) and protea...

Descripción completa

Detalles Bibliográficos
Autores principales: Asano, Yosuke, Matsumoto, Yoshinori, Wada, Jun, Rottapel, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996189/
https://www.ncbi.nlm.nih.gov/pubmed/36911671
http://dx.doi.org/10.3389/fimmu.2023.1120710
_version_ 1784902990126120960
author Asano, Yosuke
Matsumoto, Yoshinori
Wada, Jun
Rottapel, Robert
author_facet Asano, Yosuke
Matsumoto, Yoshinori
Wada, Jun
Rottapel, Robert
author_sort Asano, Yosuke
collection PubMed
description Ubiquitin-mediated proteasomal degradation is a post-transcriptional protein modification that is comprised of various components including the 76-amino acid protein ubiquitin (Ub), Ub-activating enzyme (E1), Ub-conjugating enzyme (E2), ubiquitin ligase (E3), deubiquitinating enzyme (DUB) and proteasome. We and others have recently provided genetic evidence showing that E3-ubiquitin ligases are associated with bone metabolism, the immune system and inflammation through ubiquitylation and subsequent degradation of their substrates. Dysregulation of the E3-ubiquitin ligase RNF146-mediated degradation of the adaptor protein 3BP2 (SH3 domain-binding protein 2) causes cherubism, an autosomal dominant disorder associated with severe inflammatory craniofacial dysmorphia syndrome in children. In this review, on the basis of our discoveries in cherubism, we summarize new insights into the roles of E3-ubiquitin ligases in the development of human disorders caused by an abnormal osteoimmune system by highlighting recent genetic evidence obtained in both human and animal model studies.
format Online
Article
Text
id pubmed-9996189
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99961892023-03-10 E3-ubiquitin ligases and recent progress in osteoimmunology Asano, Yosuke Matsumoto, Yoshinori Wada, Jun Rottapel, Robert Front Immunol Immunology Ubiquitin-mediated proteasomal degradation is a post-transcriptional protein modification that is comprised of various components including the 76-amino acid protein ubiquitin (Ub), Ub-activating enzyme (E1), Ub-conjugating enzyme (E2), ubiquitin ligase (E3), deubiquitinating enzyme (DUB) and proteasome. We and others have recently provided genetic evidence showing that E3-ubiquitin ligases are associated with bone metabolism, the immune system and inflammation through ubiquitylation and subsequent degradation of their substrates. Dysregulation of the E3-ubiquitin ligase RNF146-mediated degradation of the adaptor protein 3BP2 (SH3 domain-binding protein 2) causes cherubism, an autosomal dominant disorder associated with severe inflammatory craniofacial dysmorphia syndrome in children. In this review, on the basis of our discoveries in cherubism, we summarize new insights into the roles of E3-ubiquitin ligases in the development of human disorders caused by an abnormal osteoimmune system by highlighting recent genetic evidence obtained in both human and animal model studies. Frontiers Media S.A. 2023-02-23 /pmc/articles/PMC9996189/ /pubmed/36911671 http://dx.doi.org/10.3389/fimmu.2023.1120710 Text en Copyright © 2023 Asano, Matsumoto, Wada and Rottapel https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Asano, Yosuke
Matsumoto, Yoshinori
Wada, Jun
Rottapel, Robert
E3-ubiquitin ligases and recent progress in osteoimmunology
title E3-ubiquitin ligases and recent progress in osteoimmunology
title_full E3-ubiquitin ligases and recent progress in osteoimmunology
title_fullStr E3-ubiquitin ligases and recent progress in osteoimmunology
title_full_unstemmed E3-ubiquitin ligases and recent progress in osteoimmunology
title_short E3-ubiquitin ligases and recent progress in osteoimmunology
title_sort e3-ubiquitin ligases and recent progress in osteoimmunology
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996189/
https://www.ncbi.nlm.nih.gov/pubmed/36911671
http://dx.doi.org/10.3389/fimmu.2023.1120710
work_keys_str_mv AT asanoyosuke e3ubiquitinligasesandrecentprogressinosteoimmunology
AT matsumotoyoshinori e3ubiquitinligasesandrecentprogressinosteoimmunology
AT wadajun e3ubiquitinligasesandrecentprogressinosteoimmunology
AT rottapelrobert e3ubiquitinligasesandrecentprogressinosteoimmunology